How to buy Hancock Jaffe Laboratories stock (HJLI)

Hancock Jaffe Laboratories is a medical devices business based in the US. Hancock Jaffe Laboratories shares (HJLI) are listed on the NASDAQ and all prices are listed in US Dollars. Hancock Jaffe Laboratories employs 19 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Hancock Jaffe Laboratories stock

Buy Hancock Jaffe Laboratories stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Hancock Jaffe Laboratories stock price (NASDAQ: HJLI)

Use our graph to track the performance of HJLI stocks over time.

Hancock Jaffe Laboratories shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$9.02
200-day moving average more info button	$6.95
Wall St. target price	$26.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-2.71

Is it a good time to buy Hancock Jaffe Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Hancock Jaffe Laboratories financials

Gross profit TTM	$-4,252,249
Return on assets TTM	-30.58%
Return on equity TTM	-55.76%
Profit margin	0%
Book value	$4.80
Market Capitalization more info button	$98.3 million

TTM: trailing 12 months

Hancock Jaffe Laboratories share dividends

We're not expecting Hancock Jaffe Laboratories to pay a dividend over the next 12 months.

Have Hancock Jaffe Laboratories's shares ever split?

Hancock Jaffe Laboratories's shares were split on a 1:25 basis on 29 November 2020 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hancock Jaffe Laboratories shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Hancock Jaffe Laboratories shares which in turn could have impacted Hancock Jaffe Laboratories's share price.

Hancock Jaffe Laboratories share price volatility

Over the last 12 months, Hancock Jaffe Laboratories's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hancock Jaffe Laboratories's is 1.5404. This would suggest that Hancock Jaffe Laboratories's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Hancock Jaffe Laboratories overview

Hancock Jaffe Laboratories, Inc. , a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA. .

Frequently asked questions

null
What percentage of Hancock Jaffe Laboratories is owned by insiders or institutions?
Currently 9.636% of Hancock Jaffe Laboratories shares are held by insiders and 23.169% by institutions. How many people work for Hancock Jaffe Laboratories?
Latest data suggests 19 work at Hancock Jaffe Laboratories. When does the fiscal year end for Hancock Jaffe Laboratories?
Hancock Jaffe Laboratories's fiscal year ends in December. Where is Hancock Jaffe Laboratories based?
Hancock Jaffe Laboratories's address is: 70 Doppler, Irvine, CA, United States, 92618 What is Hancock Jaffe Laboratories's ISIN number?
Hancock Jaffe Laboratories's international securities identification number is: US29415J1060 What is Hancock Jaffe Laboratories's CUSIP number?
Hancock Jaffe Laboratories's Committee on Uniform Securities Identification Procedures number is: 41015N106